Memory Care Partner

记忆护理伙伴

基本信息

  • 批准号:
    9521591
  • 负责人:
  • 金额:
    $ 13.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-30 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): THE MEMORY CARE NAVIGATOR: A PROACTIVE GUIDE Memory loss is an increasing problem as our population ages, causing a tremendous personal and societal toll in disability and cost. Alzheimer's disease (AD), the most common cause of dementia, is the illness elderly Americans most fear and the only major illness with an increasing mortality rate. Despite substantial advances in the evaluation and management of dementing diseases, there has been little change in clinical care. Patients and their families too often are unsure when and how to seek care and find themselves on a prolonged odyssey to seek advice as they become lost in a confusing, complex web of uncoordinated care. The Memory Care Partner (Partner) is an innovative mobile application allowing dementia specialists to guide individuals concerned about memory loss in themselves or a family member through the complicated process of seeking care, determining a definitive case and utilizing the latest management techniques to assure the highest quality care. Partner takes advantage of Proactive Dementia Care (PDC), a coordinated, multidisciplinary prevention-focused approach pioneered at the University of Utah Center for Alzheimer's Care, Imaging and Research. PDC integrates health education and family support at the initial medical evaluation of memory loss tailoring recommendations to the specific cause of memory loss and individual circumstances. Understanding the illness and through developing a unified family plan of progressive support, patients and their family members and friends develop a care team and become empowered to manage day-to-day needs and become prepared to prevent unnecessary foreseeable complications. PAMS, Inc., a University start-up company, recognizes that a new strategy using digital technology could broadly disseminate and better achieve the goals of PDC. An experienced interdisciplinary team of 3 highly experienced dementia specialists serves as Principal Investigators of the project and provide the critical expertise needed for successful product design and relevance to everyday patient evaluation and management. In alliance with another University start-up company, ViSUS LLC, we have developed a user-friendly prototype of Partner and now propose enhancements to develop a commercial product ready for marketing and sustainment with private investment. The primary markets for Partner are individuals worried about their own memory; those concerned about memory loss in a family member or friend; and health providers. These highly motivated individuals will find in Partner a personalized, accessible and interactive guide to high quality care from first concerns through each phase of a progressive dementing disease with checklists, informational sidebars and local resources. Using Partner the care team can monitor progress of achieving management goals and actively participate in dignified and respectful care that provides a high quality of life.
 描述(由申请人提供):记忆护理导航:一个积极的指南记忆丧失是一个日益严重的问题,随着我们的人口老龄化,造成巨大的个人和社会损失的残疾和成本。阿尔茨海默病(AD)是痴呆症最常见的原因,是美国老年人最害怕的疾病,也是死亡率上升的唯一主要疾病。尽管在痴呆症的评估和管理方面取得了重大进展,但临床护理几乎没有变化。患者及其家属往往不确定何时以及如何寻求护理,并发现自己在漫长的奥德赛中寻求建议,因为他们迷失在混乱,复杂的不协调护理网络中。Memory Care Partner(伙伴)是一个创新的移动的应用程序,允许痴呆症专家指导关心自己或家庭成员记忆丧失的个人通过寻求护理的复杂过程,确定一个明确的情况下,并利用最新的管理技术,以确保最高质量的护理。合作伙伴利用主动痴呆症护理(PDC),一个协调,多学科的预防为重点的方法在犹他州大学阿尔茨海默氏症护理,成像和研究中心开创的优势。PDC将健康教育和家庭支持整合在记忆丧失的初步医学评估中,针对记忆丧失的具体原因和个人情况提出建议。通过了解疾病并制定统一的渐进式支持家庭计划,患者及其家人和朋友建立了一个护理团队,并有能力管理日常需求,并准备好预防不必要的可预见并发症。PAMS,Inc.,一家大学初创公司认识到,使用数字技术的新战略可以广泛传播并更好地实现PDC的目标。由3名经验丰富的痴呆症专家组成的经验丰富的跨学科团队担任该项目的主要研究者,并提供成功产品设计所需的关键专业知识以及与日常患者评估和管理的相关性。与另一家大学初创公司ViSUS LLC合作,我们开发了一个用户友好的合作伙伴原型,现在提出了改进措施,以开发一个商业产品,准备与私人投资进行营销和维护。合作伙伴的主要市场是担心自己记忆力的个人;那些担心家庭成员或朋友记忆力丧失的人;以及健康提供者。这些积极性很高的人将在Partner中找到个性化的、可访问的和互动的高质量护理指南,从第一个问题到进行性痴呆疾病的每个阶段,包括检查表、信息侧栏和当地资源。使用Partner,护理团队可以监控实现管理目标的进度,并积极参与提供高质量生活的有尊严和尊重的护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Troy Andersen其他文献

Troy Andersen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Troy Andersen', 18)}}的其他基金

The Memory Care Navigator: A Proactive Guide
记忆护理导航器:主动指南
  • 批准号:
    8462104
  • 财政年份:
    2012
  • 资助金额:
    $ 13.4万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341426
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341424
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政​​策的情绪动态
  • 批准号:
    10108433
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
  • 批准号:
    24K13490
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
  • 批准号:
    EP/Z00022X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
  • 批准号:
    MR/Y003365/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
  • 批准号:
    2335955
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
  • 批准号:
    AH/Y007549/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了